NO933699D0 - Sulfaterte polysakkarider som hemmere av glatt muskelcelleproliferasjon - Google Patents

Sulfaterte polysakkarider som hemmere av glatt muskelcelleproliferasjon

Info

Publication number
NO933699D0
NO933699D0 NO1993933699A NO933699A NO933699D0 NO 933699 D0 NO933699 D0 NO 933699D0 NO 1993933699 A NO1993933699 A NO 1993933699A NO 933699 A NO933699 A NO 933699A NO 933699 D0 NO933699 D0 NO 933699D0
Authority
NO
Norway
Prior art keywords
cell
priferation
polysaccarides
sulphated
inhibitors
Prior art date
Application number
NO1993933699A
Other languages
English (en)
Other versions
NO933699L (no
Inventor
H Edward Conrad
Peter Fugedi
Brian K Brandley
Lun H Lam
Roger A Laine
Original Assignee
Glycomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomed Inc filed Critical Glycomed Inc
Publication of NO933699D0 publication Critical patent/NO933699D0/no
Publication of NO933699L publication Critical patent/NO933699L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO933699A 1991-04-17 1993-10-14 Sulfaterte polysakkarider som hemmere av glatt muskelcelleproliferasjon NO933699L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68654091A 1991-04-17 1991-04-17
PCT/US1992/003092 WO1992018546A1 (en) 1991-04-17 1992-04-15 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation

Publications (2)

Publication Number Publication Date
NO933699D0 true NO933699D0 (no) 1993-10-14
NO933699L NO933699L (no) 1993-12-07

Family

ID=24756732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933699A NO933699L (no) 1991-04-17 1993-10-14 Sulfaterte polysakkarider som hemmere av glatt muskelcelleproliferasjon

Country Status (6)

Country Link
EP (1) EP0582665A1 (no)
JP (1) JPH06506973A (no)
AU (1) AU1902592A (no)
CA (1) CA2108569A1 (no)
NO (1) NO933699L (no)
WO (1) WO1992018546A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
AUPO556297A0 (en) * 1997-03-11 1997-04-10 Australian National University, The Sulfated oligosaccharides having anticoagulant/ antithrombotic activity
AUPO888497A0 (en) * 1997-09-01 1997-09-25 Australian National University, The Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
AUPO976897A0 (en) 1997-10-14 1997-11-06 Australian National University, The Use of sulfated oligosaccharides in lowering blood triglyceride levels
EP1165097B1 (en) * 1999-02-01 2007-05-02 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and their use
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US20060293275A1 (en) * 2004-03-29 2006-12-28 Toshikazu Nakamura Hgf production accelerator containing heparin-like oligosaccharide
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1992018546A1 (en) 1992-10-29
EP0582665A1 (en) 1994-02-16
AU1902592A (en) 1992-11-17
NO933699L (no) 1993-12-07
CA2108569A1 (en) 1992-10-18
JPH06506973A (ja) 1994-08-04

Similar Documents

Publication Publication Date Title
DK115791D0 (da) Heparinfragmenter som inhibitorer af proliferering af glatte muskelceller
NO20013335L (no) Anvendelse av 4-H-1-benzopyran-4-on-derivater som inhibitorer av glatt muskelcelle proliferering
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
NO932127D0 (no) Imidatderivater av farmasoeytisk nyttige antikonvulserendesulfamater
NO923944L (no) Derivater og analoger av 2-deoksy-2,3-didehydro-n-acetyl-neuraminsyre og anvendelse av disse som virusmotvirkende midler
DK0752885T3 (da) Terapeutisk inhibitor for celler i den glatte karmuskulatur
FI980033A0 (fi) Solujen kiinnittymisen inhibiittoreita
DK42093D0 (da) Administrationsmetode
NO921217D0 (no) Silyletere av rapamycin
NO921976D0 (no) Amidestere av rapamycin
FI945996A0 (fi) L-aspartyyli-D-alfa-Aminoalkanoyyli-(S)-N-alfa-Alkyylibentsyyliamidit, jotka ovat käyttökelpoisia keinotekoisina makeutusaineina
DE68905516D1 (de) Hemmungsmittel des zellwachstums der glatten muskeln.
FR2631233B1 (fr) Comprime de chlorhydrate de ranitidine enrobe
NO933699D0 (no) Sulfaterte polysakkarider som hemmere av glatt muskelcelleproliferasjon
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
KR950703064A (ko) 세포증식의 저해물질, 그의 제조방법 및 이용방법
FI932454A (fi) Ansiktsemulsionskompositioner som laemnas pao huden
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
DK0830345T3 (da) Styryl-benzimidazol-derivater som inhibitorer af glatmuskel-celleproliferation
NO974651D0 (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
NO171701C (no) Anvendelse av n-decyltioetylamin som mikrobiocid
NO912276L (no) Heparinfragmenter som hemmere av proliferasjon av glatte muskelceller.
DK36193D0 (da) Fremgangsmaade
KR970042860U (ko) 트레일링 아암의 충격 흡수구조
KR970038881U (ko) 엘리베이터의 휠체어 회동장치